T1	Participants 316 391	patients undergoing lower third molar surgical extraction with bone removal
T2	Participants 393 435	Patients who qualified for the prospective
T3	Participants 935 1060	There were 86 patients (31 in the single-dose group, 28 in the 5-day group and 27 in the placebo group) enrolled in the study
T4	Participants 1073 1169	no statistically significant differences in postoperative inflammatory complications in patients
T5	Participants 1358 1428	not show statistically significant differences between examined groups
